SKI Market

Indian Indices

Nifty

25,090.70 122.30
(0.49%)

Sensex

82,200.34 442.61
( 0.54%)

Bank Nifty

56,952.75 669.75
( 1.19%)

Nifty IT

37,031.75 -110.10
( -0.30%)

Global Indices

Nasdaq

44,363.41 142.09
(-0.32%)

Dow Jones

6,317.35 -1.01
(-0.02%)

Hang Seng

39,788.57 -112.62
(-0.28%)

Nikkei 225

8,992.12 19.48
(0.22%)

Forex

USD-INR

85.99 0.08
(0.09%)

EUR-INR

99.75 -0.09
(-0.09%)

GBP-INR

115.25 0.11
(0.09%)

JPY-INR

0.58 0.00
(0.02%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Marksans Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524404

INE750C01026

30.5295026

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MARKSANS

61.76

11587.4

EPS(TTM)

Face Value()

Div & Yield %

4.14

0.31

Back

axis bank ltd

HCL Technologies consolidated net profit declines 9.73% in the June 2025 quarter

Jul 15,2025

Net profit of HCL Technologies declined 9.73% to Rs 3843.00 crore in the quarter ended June 2025 as against Rs 4257.00 crore during the previous quarter ended June 2024. Sales rose 8.17% to Rs 30349.00 crore in the quarter ended June 2025 as against Rs 28057.00 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	30349.00	28057.00	8
OPM %	19.89	20.65	-
PBDT	6282.00	6705.00	-6
PBT	5189.00	5707.00	-9
NP	3843.00	4257.00	-10

25,090.70 122.30 (0.49%)

82,200.34 442.61 ( 0.54%)

56,952.75 669.75 ( 1.19%)

37,031.75 -110.10 ( -0.30%)

44,363.41 142.09 (-0.32%)

6,317.35 -1.01 (-0.02%)

39,788.57 -112.62 (-0.28%)

8,992.12 19.48 (0.22%)

85.99 0.08 (0.09%)

99.75 -0.09 (-0.09%)

115.25 0.11 (0.09%)

0.58 0.00 (0.02%)